Treatment cuts risk of death and recurrence, but some women still go without. July 29, 2011— -- For women diagnosed with hormone-sensitive breast cancer-- more than 150,000 in the U.S. each year- ...
Response to Cyclophosphamide, Methotrexate, and Fluorouracil in Lymph Node–Positive Breast Cancer According to HER2 Overexpression and Other Tumor Biologic Variables PURPOSE: To identify predictors of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback